Xenothera Blog XENOTHERA : publication of the first-in-human trial of LIS1 in Solid Organ Transplantation
February, 2024. For almost ten years, XENOTHERA has been committed to tackling...
Read full article »
Xenothera is a France-based biotechnology company that develops and commercializes immunotherapies for the treatment of cancer and infectious diseases.
Read more